| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/OXFORDJOURNALS.AJE.A119902 |
| P698 | PubMed publication ID | 13478579 |
| P2093 | author name string | L FINBERG | |
| R CHANOCK | |||
| P433 | issue | 3 | |
| P921 | main subject | coryza | Q2701655 |
| chimpanzee | Q4126704 | ||
| P304 | page(s) | 291-300 | |
| P577 | publication date | 1957-11-01 | |
| P1433 | published in | American Journal of Hygiene | Q26842247 |
| P1476 | title | Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children | |
| P478 | volume | 66 |
| Q64381547 | Q64381547 |
| Q92219117 | A Contemporary View of Respiratory Syncytial Virus (RSV) Biology and Strain-Specific Differences |
| Q42791762 | A comparative study of methods for the diagnosis of respiratory virus infections in childhood |
| Q39615678 | AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats |
| Q39663577 | AN AETIOLOGICAL STUDY OF RESPIRATORY INFECTION IN CHILDREN, EDINBURGH CITY HOSPITAL, 1961-1963. |
| Q39027049 | Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection |
| Q35895939 | Acute Respiratory Infections in Children: I. An Intensive Study of Etiology in an Open Community. |
| Q45717081 | Acute respiratory diseases of viral etiology. IV. Respiratory syncytial virus |
| Q92021897 | Antibody development for preventing the human respiratory syncytial virus pathology |
| Q34504791 | Biological challenges and technological opportunities for respiratory syncytial virus vaccine development |
| Q27010165 | Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity |
| Q35177143 | Biophysical studies of respiratory syncytial virus. II. Identification of two soluble complement-fixing antigens of respiratory syncytial virus |
| Q39289391 | Challenges and opportunities for respiratory syncytial virus vaccines |
| Q28776105 | Comparative virology of primates |
| Q92733658 | Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection |
| Q45777344 | Dynamics of bovine respiratory syncytial virus infections: a longitudinal epidemiological study in dairy herds |
| Q36922491 | Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope |
| Q86924716 | Etymologia: syncytium |
| Q90401234 | Host Components Contributing to Respiratory Syncytial Virus Pathogenesis |
| Q90747138 | Host and Viral Factors in Respiratory Syncytial Virus Infection |
| Q38163544 | Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections |
| Q34307704 | Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. |
| Q34043293 | Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse |
| Q34910434 | In Memoriam: Robert M. Chanock, MD, 1924–2010. |
| Q27021304 | Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design |
| Q34180049 | Innate immune recognition of respiratory syncytial virus infection |
| Q37332129 | Innate immune response and bronchiolitis and preschool recurrent wheeze |
| Q35562475 | Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children |
| Q89985650 | Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting |
| Q33837530 | Mucosal vaccines against respiratory syncytial virus |
| Q36482799 | Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infants |
| Q40130924 | Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. |
| Q38628928 | New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV. |
| Q34289051 | Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine. |
| Q35893234 | Pediatric infections |
| Q40266020 | Perinatal lamb model of respiratory syncytial virus (RSV) infection |
| Q34290125 | Pharmacokinetics-Pharmacodynamics of a Respiratory Syncytial Virus Fusion Inhibitor in the Cotton Rat Model |
| Q37841269 | Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention |
| Q35566601 | Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years |
| Q47108657 | Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity? |
| Q34574631 | RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology |
| Q84946867 | Respiratory Syncytial Virus |
| Q55534670 | Respiratory Syncytial Virus Vaccine Approaches: a Current Overview. |
| Q38258808 | Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis |
| Q37365358 | Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans |
| Q69723703 | Respiratory syncytial virus infections |
| Q35937914 | Respiratory syncytial virus infections in children in Montreal: a retrospective study |
| Q36548781 | Respiratory syncytial virus ts mutants and nuclear immunofluorescence |
| Q39817548 | Respiratory syncytial virus. Brief review |
| Q35674155 | Respiratory syncytial virus: the virus, the disease and the immune response |
| Q39325099 | Respiratory virus disease in Malaysian children: a serological study |
| Q24671895 | SURVIVAL OF THE RESPIRATORY SYNCYTIAL VIRUS DURING STORAGE UNDER VARIOUS CONDITIONS |
| Q40678270 | The clinical picture presented by premature neonates infected with the respiratory syncytial virus |
| Q37263779 | The host response and molecular pathogenesis associated with respiratory syncytial virus infection |
| Q79215144 | The present status of the problem of the minor respiratory diseases |
| Q28749631 | The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation |
| Q42530266 | Viral agents of acute respiratory infections in young children in Kuala Lumpur |
| Q46918411 | Viral etiology of acute childhood respiratory infections in Bangui, Central African Republic |
| Q36114991 | Viruses as precipitants of asthma symptoms. I. Epidemiology |
| Q41761758 | Viruses in infections of the respiratory tract. 2. |
| Q55009244 | Viruses isolated from natural common colds in the U.S.A. |
| Q79425574 | Viruses of diseases of the respiratory tract |
| Q54361250 | [Investigations on the occurrence of neutralizing antibodies against respiratory syncytial virus in the population]. |
Search more.